InsiderTrades.com logo

OVID Insider Trading

Insider Ownership Percentage: 13.10%
Insider Buying (Last 12 Months): $4,971.30
Insider Selling (Last 12 Months): $0.00

Ovid Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Ovid Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Ovid Therapeutics Share Price & Price History

Current Price: $1.62
Price Change: ▲ Price Increase of +0.04 (2.53%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for OVID up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Ovid Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/27/2025Margaret A AlexanderCOOBuy6,810$0.73$4,971.3034,935View SEC Filing Icon  
3/18/2024Jeremy M LevinCEOBuy18,248$2.76$50,364.483,616,715View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Ovid Therapeutics (NASDAQ:OVID)

72.24% of Ovid Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at OVID by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Ovid Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Qube Research & Technologies Ltd25,277$33K0.0%-65.3%0.035%Search for SEC Filing on Google Icon
11/17/2025Parkman Healthcare Partners LLC202,978$0.26M0.0%N/A0.285%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC986,293$1.28M0.0%-6.3%1.385%Search for SEC Filing on Google Icon
11/17/2025Integrated Wealth Concepts LLC52,900$69K0.0%N/A0.074%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE362,707$0.47M0.0%+2,333.0%0.509%Search for SEC Filing on Google Icon
11/17/2025Boothbay Fund Management LLC486,877$0.63M0.0%N/A0.684%Search for SEC Filing on Google Icon
11/14/2025Schonfeld Strategic Advisors LLC883,154$1.15M0.0%N/A1.240%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP341,134$0.44M0.0%N/A0.480%Search for SEC Filing on Google Icon
11/14/2025Squarepoint Ops LLC114,923$0.15M0.0%-48.0%0.162%Search for SEC Filing on Google Icon
11/13/2025Kennedy Capital Management LLC1,106,638$1.44M0.0%-26.3%1.556%Search for SEC Filing on Google Icon
11/13/2025Private Advisor Group LLC25,600$33K0.0%N/A0.036%Search for SEC Filing on Google Icon
11/10/2025Persistent Asset Partners Ltd46,040$60K0.0%N/A0.065%Search for SEC Filing on Google Icon
11/7/2025GSA Capital Partners LLP265,993$0.35M0.0%-64.2%0.374%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.2,820,813$3.67M0.0%+7.0%3.967%Search for SEC Filing on Google Icon
11/4/2025TLS Advisors LLC18,858$26K0.1%-97.2%0.027%Search for SEC Filing on Google Icon
10/17/2025Apollon Wealth Management LLC27,500$36K0.0%N/A0.039%Search for SEC Filing on Google Icon
10/7/2025Assenagon Asset Management S.A.924,576$1.20M0.0%+112.2%1.300%Search for SEC Filing on Google Icon
8/15/2025Rosalind Advisors Inc.500,000$0.17M0.1%N/A0.703%Search for SEC Filing on Google Icon
8/15/2025Rubric Capital Management LP478,533$0.16M0.0%-91.0%0.673%Search for SEC Filing on Google Icon
8/14/2025Jane Street Group LLC142,597$47K0.0%N/A0.201%Search for SEC Filing on Google Icon
8/14/2025Velan Capital Investment Management LP160,000$53K0.1%+64.9%0.225%Search for SEC Filing on Google Icon
8/13/2025Marshall Wace LLP164,721$54K0.0%N/A0.232%Search for SEC Filing on Google Icon
8/13/2025Kennedy Capital Management LLC1,502,329$0.50M0.0%-13.3%2.113%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC643,335$0.21M0.0%-51.7%0.905%Search for SEC Filing on Google Icon
8/1/2025Y Intercept Hong Kong Ltd160,306$53K0.0%N/A0.225%Search for SEC Filing on Google Icon
7/11/2025Assenagon Asset Management S.A.435,620$0.14M0.0%-22.3%0.613%Search for SEC Filing on Google Icon
6/27/2025Goldman Sachs Group Inc.104,435$33K0.0%-47.3%0.147%Search for SEC Filing on Google Icon
5/21/2025Acadian Asset Management LLC2,088,046$0.65M0.0%+12.8%2.936%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.104,435$33K0.0%-47.3%0.147%Search for SEC Filing on Google Icon
5/16/2025Jacobs Levy Equity Management Inc.200,593$63K0.0%-31.2%0.282%Search for SEC Filing on Google Icon
5/16/2025Adage Capital Partners GP L.L.C.1,150,000$0.36M0.0%+15.0%1.617%Search for SEC Filing on Google Icon
5/14/2025Affinity Asset Advisors LLC667,516$0.21M0.0%N/A0.939%Search for SEC Filing on Google Icon
5/12/2025Nuveen LLC119,113$37K0.0%N/A0.168%Search for SEC Filing on Google Icon
5/8/2025XTX Topco Ltd93,154$29K0.0%N/A0.131%Search for SEC Filing on Google Icon
4/15/2025Assenagon Asset Management S.A.560,830$0.18M0.0%+699.9%0.789%Search for SEC Filing on Google Icon
2/17/2025Velan Capital Investment Management LP70,000$65K0.1%N/A0.099%Search for SEC Filing on Google Icon
2/17/2025Madison Avenue Partners LP3,722,627$3.48M0.4%-9.6%5.242%Search for SEC Filing on Google Icon
2/17/2025OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC943,416$0.88M0.1%+50.2%1.329%Search for SEC Filing on Google Icon
2/17/2025Jacobs Levy Equity Management Inc.291,701$0.27M0.0%N/A0.411%Search for SEC Filing on Google Icon
2/17/2025Bridgeway Capital Management LLC229,115$0.21M0.0%-26.0%0.323%Search for SEC Filing on Google Icon
2/17/2025Bank of America Corp DE56,733$53K0.0%+49.7%0.080%Search for SEC Filing on Google Icon
2/17/2025BNP Paribas Financial Markets104,712$98K0.0%-52.5%0.147%Search for SEC Filing on Google Icon
2/14/2025Adage Capital Partners GP L.L.C.1,000,000$0.93M0.0%N/A1.408%Search for SEC Filing on Google Icon
2/13/2025Kennedy Capital Management LLC1,545,387$1.44M0.0%+1.1%2.176%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC107,700$0.10M0.0%+142.0%0.152%Search for SEC Filing on Google Icon
2/13/2025ADAR1 Capital Management LLC130,532$0.12M0.0%+245.8%0.184%Search for SEC Filing on Google Icon
2/12/2025TLS Advisors LLC680,967$0.64M1.5%-11.7%0.959%Search for SEC Filing on Google Icon
2/12/2025Takeda Pharmaceutical Co. Ltd.7,531,996$7.01M26.4%N/A10.607%Search for SEC Filing on Google Icon
2/12/2025JPMorgan Chase & Co.1,418,306$1.32M0.0%-3.1%1.997%Search for SEC Filing on Google Icon
2/10/2025Monimus Capital Management LP138,266$0.13M0.1%N/A0.195%Search for SEC Filing on Google Icon
1/30/2025Rhumbline Advisers84,078$79K0.0%+22.3%0.118%Search for SEC Filing on Google Icon
1/17/2025SG Americas Securities LLC37,636$35K0.0%+83.9%0.053%Search for SEC Filing on Google Icon
1/14/2025Assenagon Asset Management S.A.70,114$65K0.0%-18.7%0.099%Search for SEC Filing on Google Icon
11/19/2024Barclays PLC84,175$98K0.0%+311.2%0.119%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC1,317,330$1.56M0.0%+1.1%1.855%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC84,175$98K0.0%+311.2%0.119%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd38,230$45K0.0%+46.2%0.054%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC38,399$45K0.0%-61.1%0.054%Search for SEC Filing on Google Icon
11/14/2024Verition Fund Management LLC74,875$88K0.0%N/A0.105%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets220,401$0.26M0.0%+4,128.7%0.311%Search for SEC Filing on Google Icon
11/13/2024FMR LLC50,225$59K0.0%+1,907.4%0.071%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP260,509$0.31M0.0%+118.0%0.367%Search for SEC Filing on Google Icon
10/23/2024Assenagon Asset Management S.A.86,289$0.10M0.0%N/A0.122%Search for SEC Filing on Google Icon
8/16/2024Driehaus Capital Management LLC1,400,191$1.08M0.0%N/A1.974%Search for SEC Filing on Google Icon
8/13/2024DCF Advisers LLC41,750$32K0.0%+111.6%0.059%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC141,200$0.11M0.0%-9.9%0.199%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP274,982$0.21M0.0%-19.6%0.388%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers69,733$54K0.0%-15.6%0.098%Search for SEC Filing on Google Icon
8/1/2024FFT Wealth Management LLC489,552$0.38M0.0%+18.2%0.690%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp218,163$0.17M0.0%-5.0%0.308%Search for SEC Filing on Google Icon
5/16/2024BVF Inc. IL3,853,818$11.75M0.3%-43.7%5.442%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD17,396$54K0.0%+22.1%0.025%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.2,976,308$9.08M0.0%-0.5%4.203%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC35,938$0.11M0.0%-9.7%0.051%Search for SEC Filing on Google Icon
5/7/2024Empowered Funds LLC128,070$0.39M0.0%+8.1%0.181%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets32,162$98K0.0%+74.7%0.045%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.13,579$41K0.0%+66.0%0.019%Search for SEC Filing on Google Icon
4/24/2024Assenagon Asset Management S.A.114,265$0.35M0.0%+45.6%0.162%Search for SEC Filing on Google Icon
2/14/2024Rubric Capital Management LP5,315,969$17.12M0.4%-2.4%7.521%Search for SEC Filing on Google Icon
2/14/2024Vestal Point Capital LP85,429$0.28M0.0%N/A0.121%Search for SEC Filing on Google Icon
2/13/2024DCF Advisers LLC18,730$60K0.0%-38.4%0.026%Search for SEC Filing on Google Icon
2/6/2024FFT Wealth Management LLC395,774$1.27M0.1%N/A0.560%Search for SEC Filing on Google Icon
1/24/2024China Universal Asset Management Co. Ltd.8,178$26K0.0%N/A0.012%Search for SEC Filing on Google Icon
1/17/2024Assenagon Asset Management S.A.78,479$0.25M0.0%N/A0.111%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC39,792$0.13M0.0%+52.7%0.056%Search for SEC Filing on Google Icon
11/13/2023Connor Clark & Lunn Investment Management Ltd.81,173$0.31M0.0%+17.2%0.115%Search for SEC Filing on Google Icon
11/13/2023Acadian Asset Management LLC1,701,228$6.53M0.0%-4.5%2.407%Search for SEC Filing on Google Icon
11/7/2023New York State Common Retirement Fund19,110$73K0.0%-28.7%0.027%Search for SEC Filing on Google Icon
11/7/2023Jump Financial LLC15,811$61K0.0%N/A0.022%Search for SEC Filing on Google Icon
10/13/2023SG Americas Securities LLC26,064$100K0.0%N/A0.037%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC11,955$40K0.0%N/A0.017%Search for SEC Filing on Google Icon
8/11/2023Rubric Capital Management LP5,445,910$17.86M0.8%-22.2%7.714%Search for SEC Filing on Google Icon
8/11/2023Tejara Capital Ltd112,591$0.37M0.2%-5.2%0.159%Search for SEC Filing on Google Icon
8/9/2023DCF Advisers LLC64,764$0.21M0.1%-5.1%0.092%Search for SEC Filing on Google Icon
8/4/2023American International Group Inc.28,701$94K0.0%N/A0.041%Search for SEC Filing on Google Icon
7/27/2023EA Series Trust98,952$0.33M0.0%N/A0.140%Search for SEC Filing on Google Icon
7/25/2023Raymond James & Associates25,000$82K0.0%N/A0.035%Search for SEC Filing on Google Icon
5/15/2023Madison Avenue Partners LP3,104,603$8.01M1.7%+14.1%4.402%Search for SEC Filing on Google Icon
5/15/2023Rubric Capital Management LP7,001,124$18.06M0.5%+2.5%9.928%Search for SEC Filing on Google Icon
5/12/2023Tejara Capital Ltd118,791$0.31M0.2%+10.5%0.168%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Ovid Therapeutics logo
Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. The company is developing soticlestat, a novel cholesterol 24 hydroxylase inhibitor, which is in Phase 3 clinical trials for the potential treatment of patients with resistant epilepsies; OV329, a GABA aminotransferase inhibitor which is in Phase 1 clinical trials for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule direct activator of the KCC2 transporter, which is in Phase 1 clinical trials for treating epilepsies. It also develops OV815, that focuses on the mutations associated with KIF1A-associated neurological disorder (KAND); OV888 (GV101), a highly selective rock2 inhibitor which is in Phase 1 double-blind multiple-ascending dose trial; OV825, has advanced to potential candidate lead identification for the rare neurodevelopmental condition HNRNPH2 (Bain Syndrome); and OV882, a short hairpin RNA gene therapy for the treatment of Angelman syndrome. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
Read More on Ovid Therapeutics

Today's Range

Now: $1.62
Low: $1.55
High: $1.67

50 Day Range

MA: $1.51
Low: $1.20
High: $1.84

52 Week Range

Now: $1.62
Low: $0.24
High: $2.01

Volume

1,470,837 shs

Average Volume

1,639,117 shs

Market Capitalization

$115.36 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.04

Who are the company insiders with the largest holdings of Ovid Therapeutics?

Ovid Therapeutics' top insider shareholders include:
  1. Jeremy M Levin (CEO)
  2. Margaret A Alexander (COO)
Learn More about top insider investors at Ovid Therapeutics.

Who are the major institutional investors of Ovid Therapeutics?

Ovid Therapeutics' top institutional investors include:
  1. Vanguard Group Inc. — 3.97%
  2. Kennedy Capital Management LLC — 1.56%
  3. Millennium Management LLC — 1.39%
  4. Assenagon Asset Management S.A. — 1.30%
  5. Schonfeld Strategic Advisors LLC — 1.24%
  6. Boothbay Fund Management LLC — 0.68%
Learn More about top institutional investors of Ovid Therapeutics stock.

Which institutional investors are selling Ovid Therapeutics stock?

During the last quarter, OVID stock was sold by these institutional investors:
  1. TLS Advisors LLC
  2. GSA Capital Partners LLP
  3. Kennedy Capital Management LLC
  4. Squarepoint Ops LLC
  5. Millennium Management LLC
  6. Qube Research & Technologies Ltd

Which institutional investors are buying Ovid Therapeutics stock?

Within the last quarter, OVID stock was purchased by institutional investors including:
  1. Schonfeld Strategic Advisors LLC
  2. Assenagon Asset Management S.A.
  3. Boothbay Fund Management LLC
  4. Bank of America Corp DE
  5. Two Sigma Investments LP
  6. Parkman Healthcare Partners LLC
  7. Vanguard Group Inc.
  8. Group One Trading LLC
In the last year, these company insiders have bought Ovid Therapeutics stock:
  1. Jeremy M Levin (CEO)
  2. Margaret A Alexander (COO)
Learn More investors buying Ovid Therapeutics stock.